Australian Pharmaceutical Industries Ltd (ASX: API) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Australian Pharmaceutical Industries Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Australian Pharmaceutical Industries Ltd (ASX: API)
Latest News
Mergers & Acquisitions
Today is the last hurrah for API. What does this mean for Wesfarmers (ASX:WES) shares?
Consumer Staples & Discretionary Shares
Wesfarmers (ASX:WES) now has control of API, but is the real fight just beginning?
Mergers & Acquisitions
Wesfarmers (ASX:WES) shares in focus as API deal looks all but sealed
Mergers & Acquisitions
Own Wesfarmers (ASX:WES) shares? Here’s how the numbers are looking in the API takeover vote
Ask a Fund Manager
Why my 2 biggest ASX shares are about to disappear: fund manager
Mergers & Acquisitions
Wesfarmers (ASX:WES) share price lower despite API takeover update
Retail Shares
Could this be the biggest issue faced by ASX retail shares heading into earnings season?
Consumer Staples & Discretionary Shares
Could this signal the next big acquisition for Wesfarmers (ASX:WES)?
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 24 Mar 2022 | $0.0300 | 100.00% | Special Cash | 29 Mar 2022 |
| 11 Nov 2021 | $0.0200 | 100.00% | Final | 15 Dec 2021 |
| 06 May 2021 | $0.0150 | 100.00% | Interim | 04 Jun 2021 |
| 11 Nov 2020 | $0.0200 | 100.00% | Final | 15 Dec 2020 |
| 13 Nov 2019 | $0.0400 | 100.00% | Final | 12 Dec 2019 |
| 02 May 2019 | $0.0375 | 100.00% | Interim | 31 May 2019 |
| 08 Nov 2018 | $0.0400 | 100.00% | Final | 07 Dec 2018 |
| 03 May 2018 | $0.0350 | 100.00% | Interim | 01 Jun 2018 |
| 09 Nov 2017 | $0.0350 | 100.00% | Final | 08 Dec 2017 |
| 04 May 2017 | $0.0350 | 100.00% | Interim | 02 Jun 2017 |
| 03 Nov 2016 | $0.0350 | 100.00% | Final | 09 Dec 2016 |
| 05 May 2016 | $0.0250 | 100.00% | Interim | 03 Jun 2016 |
| 04 Nov 2015 | $0.0250 | 100.00% | 04 Dec 2015 | |
| 06 May 2015 | $0.0200 | 100.00% | 05 Jun 2015 | |
| 12 Nov 2014 | $0.0200 | 100.00% | 12 Dec 2014 | |
| 07 May 2014 | $0.0150 | 100.00% | 06 Jun 2014 | |
| 11 Nov 2011 | $0.0150 | 0.00% | Final | 15 Dec 2011 |
API ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Australian Pharmaceutical Industries Ltd
Australian Pharmaceutical Industries Ltd (ASX: API) is an Australian company with three key areas of operation: retail, wholesale distribution and business advisory. The company is probably best known for its retail pharmacy and health and beauty brands, Soul Pattinson and Priceline.
Priceline was acquired by API in 2004 and has more than 420 stores Australia-wide. Priceline stores are wholly owned by API whereas Priceline Pharmacies are operated under a franchise model.
In addition to its pharmacy brands, API owns a chain of 57 cosmetic, skin and laser hair removal clinics in Australia and New Zealand called Clear Skincare Clinics. It also produces a range of products under the Clear Skincare brand which it sells through Priceline Pharmacy.
API’s operations include retail services which encompass marketing programs and business advice.
API was established in 1910 and listed on the ASX in 1997. The API share price was hit hard by the February/March 2020 bear market, falling as low as $1 on 23 March. Since then, as at October 2020, the API share price has continued trading at between $1 and $1.20.
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 29 Mar 2022 | Richard Vincent | Cancelled | 2 | $3,431,298 | Cancellation of securities. |
| 08 Feb 2022 | Richard Vincent | Issued | 731 | $1,115,888 | Issue of securities. 22,13,741 - performance rights |
| 15 Oct 2021 | Richard Vincent | Expiry | 416 | $633,770 | As advised by the company. 1,482,011 - Performance Rights Performance rights lapsed under API's Long Term Incentive Plan |
| 15 Oct 2021 | Richard Vincent | Issued | 160 | $244,568 | Issue of securities. 1,898,965 - performance rights |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Richard Craig Vincent | Chief Executive OfficerManaging Director | Feb 2017 | Mr Vincent started his professional career in finance with Bridgestone before moving to Britax Rainsfords where he was CFO. He joined FH Faulding & Co Limited (ultimately acquired by the Mayne Group) in 1998 and remained with that company until 2005, during which time he held a number of senior leadership roles, including responsibility for the pharmacy distribution, retail merchandise and generic pharmaceutical development. Mr Vincent joined API in 2005. He has held a number of general management roles including pharmacy distribution and business development, strategy, supply chain, franchise recruitment, IT, manufacturing and mergers and acquisition. Mr Vincent is the Chair of the National Pharmaceutical Services Association and was also a Director of CH2 Holdings Pty Ltd from 2006 to 2015. |
| Ms Anne Mustow | Company SecretaryGeneral Counsel | Jul 2019 | - |
| Peter Mendo | Chief Financial Officer | - | |
| Anne Mustow | Company SecretaryGeneral Counsel | - |
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Wesfarmers Limited | 95,068,472 | 19.30% |
| Citicorp Nominees Pty Limited | 80,571,205 | 16.35% |
| HSBC Custody Nominees (Australia) Limited | 64,649,846 | 13.12% |
| J P Morgan Nominees Australia Pty Limited | 47,045,778 | 9.55% |
| National Nominees Limited | 23,990,229 | 4.87% |
| Neweconomy Com Au Nominees Pty Limited <900 Account> | 10,875,648 | 2.21% |
| BNP Paribas Noms Pty Ltd <Drp> | 5,487,767 | 1.11% |
| BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> | 3,446,978 | 0.70% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 3,127,021 | 0.63% |
| Brispot Nominees Pty Ltd <House Head Nominee A/C> | 2,406,099 | 0.49% |
| J & P Chick Pty Limited <J & P Chick Pty Ltd S/F A/C> | 2,000,000 | 0.41% |
| Jum Pty Limited | 1,567,286 | 0.32% |
| Netwealth Investments Limited <Wrap Services A/C> | 1,564,064 | 0.32% |
| HSBC Custody Nominees (Australia) Limited <Gsco Customers A/C> | 1,562,450 | 0.32% |
| BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C> | 1,502,889 | 0.31% |
| BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> | 1,461,003 | 0.30% |
| Dr Jeffrey Eric Dale Chick & Dr Pamela Hazel Chick | 1,260,000 | 0.26% |
| Mr Frederick Benjamin Warmbrand <Fb & Lj Warmbrand Super A/C> | 1,240,000 | 0.25% |
| UBS Nominees Pty Ltd | 898,087 | 0.18% |
| Nulis Nominees (Australia) Limited <Navigator Mast Plan Sett A/C> | 889,410 | 0.18% |